Survivin, a member of the Inhibitor of Apoptosis Protein (IAP) family [4], has emerged few years ago as a promising therapeutic target in cancers because of its overexpression in a wide spectrum of tumors, including melanoma [5-7]. Here, BIRC5 is linked to cancer.